Positive Year Ahead Anticipated for UK M&A

The UK is expected to be one of the most popular locations for deal activity in 2019, mirroring a successful year in 2018.

Megadeals boosted the value of transactions in 2018 as, while the volume of UK deals only rose slightly, deals such as Japanese-based Takeda Pharmaceutical’s acquisition of UK-based Shire for £62bn saw a 4% increase in transaction value from £291bn the year before.